Context Therapeutics Inc. — Director's Dealing 2021

Oct 19, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Context Therapeutics Inc. (CNTX)
CIK: 0001842952
Period of Report: 2021-10-19

Reporting Person: Kantoff Philip W. (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3533	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$4.94	2031-04-30	Common Stock (15000)		Direct

Footnotes

F1: The stock option vests each month (1/36 each month) from the date of the grant, April 30, 2021.